SECsense Logo

Glucotrack, Inc. 8-K Report: Key Insights from February 14, 2025 Filing

$GCTK
Form 8-K
Filed on: 2025-02-14
Source
Glucotrack, Inc. 8-K Report: Key Insights from February 14, 2025 Filing

Based on the section of the financial report provided, here are the key insights extracted:

  1. Entity Information:
  • Company Name: Glucotrack, Inc.
  • CIK Number: 0001506983
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-41141
  • EIN: 98-0668934
  • Address: 301 Route 17 North, Suite 800, Rutherford, NJ 07070
  • Contact Number: (201) 842-7715
  1. Filing Type:
  • Form: 8-K
  • Filing Date: February 14, 2025
  1. Stock Information:
  • Common Stock Ticker Symbol: GCTK
  • Exchange: NASDAQ
  1. Reporting Context:
  • Report Date: February 14, 2025
  • Period of Report: Same day (As of February 14, 2025)
  1. Units of Measure:
  • Financial figures are reported in USD (United States Dollars).
  • Shares are also used as a unit of measure, indicating potential relevance to share price or equity transactions.
  1. Schema Reference:
  • The report references a schema file (gctk-20250214.xsd) that likely provides the structure for the XBRL data.

Insights:

  • The report is a current event filing (8-K) indicating that significant information about Glucotrack, Inc. may have been disclosed on the specified date.
  • Investors and analysts focusing on Glucotrack, Inc. should pay attention to this filing for any material events that could impact the company's stock performance or financial condition.
  • The inclusion of common stock information and the NASDAQ listing suggests ongoing liquidity and trading activity in the market for Glucotrack's shares, which is relevant for investment decisions.

This analysis highlights critical company information and contextual details relevant for stakeholders, including investors, analysts, and regulatory bodies.